drugset / Trial / NCT02865720
Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if an investigational treatment is safe and well tolerated when administered by intravenous (IV) infusion in Japanese subjects with HAE.
Timeline
- Start
- 2016-09-08
- Primary completion
- 2017-06-23
- Completion
- 2017-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CINRYZE | Protein / enzyme biologic | 500 iu | Intravenous |
| Subject | CINRYZE | Protein / enzyme biologic | 1000 iu | Intravenous |